Oscar Health Shareholders: Ownership Structure, Brands, and Acquisition History
Last updated: Sep-2026Ownership Structure
Ownership Analysis
Oscar Health has a dual-class public ownership structure. Class A shares trade on the New York Stock Exchange and carry one vote each. Class B shares carry twenty votes each and convert to Class A under specified transfer and sunset conditions. This design separates economic ownership from control and gives the founder-aligned Class B holders influence far above their percentage of total shares.Joshua Kushner and Thrive Capital affiliates remained the decisive voting block after Thrive distributed shares to its partners in September 2026. The distribution changed the holders of some economic interests but did not eliminate founder-aligned control. Oscar disclosed that Kushner and affiliated persons and funds held close to 67% of combined voting power after the distribution. No ordinary Class A institution has comparable authority.The board still owes duties to all shareholders. It approves strategy, management, capital decisions, acquisitions, and entry into insurance markets. However, the controlling vote makes it difficult for minority investors to replace directors without support from the Class B block. Supermajority provisions, limits on written consent, and insurance regulatory approvals create further barriers to an unsolicited change of control.Oscar also operates through regulated insurance subsidiaries and marketplace subsidiaries. The parent directs strategy, but insurance capital cannot be moved freely to fund repurchases or unrelated expansion. Lucie, Trove Group, and HealthInsurance.org are wholly owned businesses that support enrollment and distribution. They do not control Oscar. The legal hierarchy should therefore show the controlling shareholder block above Oscar and the operating companies beneath it.
Direct Owners
Institutional Shareholders
Shareholder Analysis
The most important Oscar shareholder is the founder-aligned Thrive group controlled by Joshua Kushner. Its significance comes from Class B voting rights, not only the number of shares held. The September 2026 distribution reduced the concentration of Thrive's investment among its funds, partners, and affiliated persons, but the disclosed group retained close to 67% of combined voting power.BlackRock was the largest outside institution identified above 5% of Class A stock in the 2026 proxy, at 5.3%. Its economic position is meaningful, yet its voting influence remains small when measured against the twenty votes attached to each Class B share. Other institutions can engage management and vote on governance, but they cannot form an effective control block without the founder-aligned holders.Mark Bertolini and other insiders also own shares through compensation and direct holdings. Their interests can align management with market value, though equity incentives must be assessed beside the controlling structure. When one block can determine elections, minority owners rely on independent directors to scrutinize medical-cost assumptions, executive pay, related-party matters, and acquisitions with the same rigor they would apply at a widely held insurer.The Class A float supports liquidity and gives Oscar access to public equity and convertible debt markets. It also exposes the price to health-policy news, enrollment changes, risk adjustment, and quarterly medical utilization. We would not confuse share-price volatility with a transfer of control. A real ownership change would require conversion, sale, or expiration of enough Class B votes to remove the present majority.
Brands, Subsidiaries & Companies Owned
| Name | Type | Description |
|---|---|---|
| Oscar | Brand | Technology-enabled individual and family health insurance |
| +Oscar | Brand | Health technology services for external clients |
| Lucie | Subsidiary | Cloud-based enrollment platform for consumers employers and brokers |
| Trove Group | Subsidiary | Individual medical and supplemental insurance agency |
| HealthInsurance.org | Subsidiary | Consumer health insurance education and lead generation |
Portfolio Analysis
Oscar is the main insurance brand. It sells individual and family health plans through federal and state marketplaces and has expanded into coverage funded through Individual Coverage Health Reimbursement Arrangements. The consumer promise combines health insurance with digital navigation, care teams, and a technology-led member experience. The insurance business still generates the vast majority of consolidated revenue.+Oscar is the technology-services identity. Its Campaign Builder product supports engagement and recommendations for outside healthcare clients as well as Oscar's own operations. +Oscar should be treated as a product platform, not as a separate listed company. Its value depends on proving that Oscar's technology can earn recurring revenue beyond the insurer's own membership base.Lucie is a cloud-based enrollment platform for consumers, employers, and brokers. Trove Group, formerly IHC Specialty Benefits, is an insurance agency selling individual medical and supplemental products. HealthInsurance.org provides consumer education and lead generation. Together these businesses create a path from research and enrollment to brokerage and Oscar coverage, especially in the developing ICHRA market.The portfolio is strategically connected, but the economics differ. Insurance absorbs medical risk and regulated capital. Brokerage and lead generation depend on traffic, conversion, carrier relationships, and acquisition costs. Technology services depend on client retention and measurable engagement results. We would expect management to show whether these assets lower Oscar's member-acquisition costs or create independent profit rather than merely adding more names to the ownership chart.
Market Share & Competitors
| Company | Market Share | Revenue | Key Strength |
|---|---|---|---|
| Oscar Health ★ | N/A | $11.70B | Technology-led individual health insurance |
| Centene | N/A | $178.2B | Medicaid and marketplace scale |
| UnitedHealth Group | N/A | $447.6B | Integrated insurance and care delivery |
| Elevance Health | N/A | $197.6B | Blue-plan reach and care services |
| Molina Healthcare | N/A | $43.6B | Government-sponsored health-plan focus |
Competitive Analysis
Oscar competes primarily in the Affordable Care Act individual market. National insurers, Blue Cross plans, regional carriers, and Medicaid-focused companies all compete for members and provider contracts. Centene is a useful public comparison because of its large marketplace position. UnitedHealth, Elevance, Molina, and Cigna bring greater scale, broader product sets, and deeper balance sheets.Oscar's main differentiation is the combination of a consumer brand, cloud-based operating platform, digital engagement, and a narrower focus on individual coverage. That focus can make product design and member tools more responsive. It also creates concentration. Oscar depends heavily on marketplace rules, subsidies, risk adjustment, and a limited number of states, with Florida representing a large share of members.Price is essential because consumers compare premiums and benefits each enrollment season. Provider networks, claims accuracy, broker relationships, and customer service are equally important. A strong app cannot compensate for an uncompetitive premium or inadequate network. Larger rivals can spread technology and regulatory costs across more businesses, while local plans may have stronger provider relationships in individual markets.We would measure Oscar's position through enrollment retention, medical loss ratio, administrative expense ratio, risk-adjustment accuracy, complaint levels, and contribution margin by market. Rapid membership growth is not enough if pricing fails to cover claims. The competitive case improves when technology lowers servicing costs and directs members to effective care without weakening network access or regulatory compliance.
Acquisitions
| Company Acquired | Deal Value | Year | Description |
|---|---|---|---|
| Lucie | N/A | 2025 | Added a direct-enrollment technology platform |
| Trove Group | N/A | 2025 | Added individual and supplemental insurance brokerage |
| HealthInsurance.org | N/A | 2025 | Added consumer education and lead-generation properties |
Acquisitions Analysis
Oscar purchased Lucie, Trove Group, and HealthInsurance.org in May 2025. The company described them as early-stage businesses that support its Individual Coverage Health Reimbursement Arrangement strategy and broader consumer marketplace. Oscar did not disclose reliable stand-alone purchase prices for the three assets, so the acquisition list should use N/A rather than invented or blank values.The strategic logic is distribution. Lucie provides an approved enhanced direct enrollment platform. Trove adds brokerage across individual medical and supplemental products. HealthInsurance.org brings educational content and consumer leads. Combined with Oscar's carrier products, the assets can help employers, brokers, and individuals move from plan research to enrollment within an ecosystem that Oscar controls more directly.Integration risk is not limited to software. Oscar must align broker practices, privacy controls, lead quality, carrier relationships, compliance, and customer service. It also needs to avoid conflicts between offering consumers a broad marketplace and steering eligible customers toward Oscar plans. The 124 employees added through the purchases indicate a meaningful operating commitment even though the businesses were described as early stage.Success should appear in lower acquisition costs, ICHRA enrollment, brokerage revenue, improved conversion, and better retention. It should not be measured only by traffic or gross member additions. Oscar has a history of narrowing or ending initiatives, including the Cigna plus Oscar small-group arrangement. That history supports a disciplined review of the new assets if they fail to improve unit economics or strategic control of distribution.
Acquisition Timeline
Merger & Spin-off History
Merger & Spin-off Analysis
Oscar has not been formed through a major corporate merger or spinoff. Its structural history is defined instead by organic insurance expansion, partnerships, public listing, and selected acquisitions. That distinction matters because the current parent is still the company founded in 2012, not the surviving shell of a combination between two similarly sized insurers.The Cigna plus Oscar relationship was a partnership rather than a merger. The companies offered co-branded small-group products, but Oscar chose not to renew the arrangement after its initial term ended in December 2024. Run-off services continue through 2026 for policies issued before the cutoff. The exit reduced small-group complexity and left Oscar focused on individual coverage and ICHRA opportunities.Oscar's 2021 initial public offering was the major capital-structure event. It introduced a public Class A float while preserving control through high-vote Class B shares. The 2025 marketplace acquisitions expanded the operating perimeter but did not alter that control. Thrive Capital's 2026 distribution changed the placement of shares among affiliated holders without functioning as a corporate spinoff.The practical lesson is that Oscar can change strategic direction without a merger. It has entered and exited markets, ended a co-branded product, acquired distribution assets, and adjusted its capital structure while the founder-aligned vote remained intact. Investors should evaluate these events separately. Partnership run-off, acquisitions, and share distributions have different effects on earnings, control, and operating integration.
Ownership History
Ownership History Analysis
Oscar Health was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi. The company entered the new Affordable Care Act marketplaces with a technology-led health insurance model and a consumer-oriented brand. Early ownership was concentrated among founders, employees, and venture investors, including Thrive Capital, before the company accessed public markets.Oscar completed its initial public offering in 2021. The listing created publicly traded Class A shares but did not produce ordinary one-share, one-vote governance. Founders and Thrive affiliates retained Class B stock with twenty votes per share. The IPO therefore broadened economic ownership and capital access while preserving control with the original investor and founder group.In 2022, Thrive and Dragoneer purchased convertible notes that supplied additional capital. Oscar later regained profitability in 2024 before reporting a 2025 loss affected by medical-cost and risk-adjustment pressures. The company also ended its Cigna small-group arrangement and bought three marketplace businesses in 2025. These moves shifted the story from a pure digital insurer toward insurance, enrollment, brokerage, and technology services.Thrive Capital distributed part of its Oscar position in September 2026. The event widened direct ownership among Thrive partners and affiliates, yet Joshua Kushner and the affiliated group retained close to 67% of total voting power. Oscar is therefore still founder-controlled. Its ownership history shows repeated capital and operating changes without a corresponding transfer of corporate control to public Class A investors. That distinction remains essential when evaluating board accountability.
Ownership Explained
Oscar Health is publicly traded, but its dual-class capital structure separates economic ownership from voting control. Joshua Kushner and Thrive-affiliated holders retained close to two-thirds of combined voting power after Thrive's September 2026 distribution. Public Class A investors participate economically while the Class B bloc can determine most shareholder votes.Oscar owns regulated insurance subsidiaries and three marketplace businesses: Lucie, Trove Group, and HealthInsurance.org. The +Oscar name covers technology services rather than a separate public company. The board remains responsible for all shareholders, yet the controlling vote gives the founder-aligned bloc durable influence over directors, strategy, and any potential change of control.
Oscar Health is public, but its shareholders do not have equal voting power per share. Class A stock carries one vote, while Class B stock carries twenty votes. After Thrive Capital's September 2026 distribution, Joshua Kushner and affiliated holders still controlled close to 67% of total voting power. Public investors own most of the freely traded economic interest, yet the founder-aligned block can decide director elections and most other shareholder votes.That control can support a longer strategy than a widely held insurer might tolerate. Oscar has invested in its technology platform, entered and exited insurance markets, and expanded membership despite volatile medical costs and risk-adjustment outcomes. The same structure limits the ability of minority owners to force change after poor results. Board independence, transparent reserve assumptions, and disciplined compensation are therefore especially important protections for Class A shareholders.Shareholders own the parent company, not the premiums held inside regulated insurance subsidiaries. State regulators require those entities to maintain capital and approve material dividends or changes of control. Oscar must first pay medical claims, comply with risk-based capital rules, and fund operations before value can move to the parent. High revenue does not translate directly into distributable cash because most premium dollars finance member healthcare.The 2025 purchases of Lucie, Trove Group, and HealthInsurance.org extended Oscar beyond underwriting into enrollment, brokerage, and consumer education. Owners now have exposure to both the insurance operation and a developing marketplace model. We would assess that strategy through member retention, medical loss ratio, selling costs, risk-adjustment accuracy, and cash generation. Founder control is valuable only if it produces better long-term decisions than the market could impose through ordinary voting.